Skip to content

Drug interactions

Canagliflozin-metformin + Nimodipine

Severity: Minor

Canagliflozin-metformin and Nimodipine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dihydropyridine calcium channel blockers have occasionally been associated with small increases in blood glucose. Clinical significance is usually minimal.

What this interaction means in plain words

Canagliflozin-metformin and Nimodipine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Canagliflozin-metformin belongs to Endocrine; Nimodipine belongs to Cardiovascular.

Evidence level: Low

Why it happens

Calcium channel blockade may slightly reduce insulin secretion; the mechanism is not firmly established.

What to do

No dose change is needed; monitor glucose as part of routine diabetes care.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Canagliflozin-metformin and Nimodipine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Canagliflozin-metformin with Nimodipine?

MediHelp rates the interaction as minor. Canagliflozin-metformin and Nimodipine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dihydropyridine calcium channel blockers have occasionally been associated with small increases in blood glucose. Clinical significance is usually minimal.

How serious is the interaction between Canagliflozin-metformin and Nimodipine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed; monitor glucose as part of routine diabetes care.

What other medicines interact with Canagliflozin-metformin?

MediHelp also lists interactions of Canagliflozin-metformin with, for example, Contrast media, Diatrizoate, Diatrizoate meglumine / diatrizoate. The full list is on the Canagliflozin-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in